Announcements Trials
Browse Landscape

Status

Recruiting 4Terminated 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Observational 6

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Gastrointestinal 2Other solid neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 60Neoplasms 58Lung Neoplasms 32Prostatic Neoplasms 24Colorectal Neoplasms 24Carcinoma, Non-Small-Cell Lung 21Neoplastic Cells, Circulating 20Head and Neck Neoplasms 19Pancreatic Neoplasms 17Melanoma 14Ovarian Neoplasms 13Carcinoma, Hepatocellular 12Esophageal Neoplasms 10Colonic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Glioma 9Squamous Cell Carcinoma of Head and Neck 8Multiple Myeloma 8Leukemia, Myeloid, Acute 8Sarcoma 7Neoplasm Metastasis 7Endometrial Neoplasms 7Stomach Neoplasms 6Neoplasm, Residual 6Myeloproliferative Disorders 6Leukemia 6Kidney Neoplasms 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6

Interventions

Blood Specimen Collection 6Radiotherapy 2Quality of Life 2Phlebotomy 2Interviews as Topic 2Drug Therapy 2zolbetuximab 1trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1iopromide 1capecitabine-irinotecan combination 1X-Rays 1Tumor Burden 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Therapeutics 1Surveys and Questionnaires 1Risedronic Acid 1Registries 1Raloxifene Hydrochloride 1Radiofrequency Ablation 1Radiation, Ionizing 1Radiation 1Positron-Emission Tomography 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Induction Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × Adenocarcinoma × Blood Specimen Collection × Clear all
NCT06996249 2026-03-03

DuTOC

Dutch Society of Physicians for Pulmonology and Tuberculosis

Recruiting
12,000 enrolled
Other solid neoplasmThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Mesothelioma, Thymus Neoplasms

NCT00349830 2026-02-10

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Stanford University

Recruiting
2,000 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasms

NCT06605404 2025-08-14

Pan-tumor MRD Study

Paradigm Health

Recruiting
1,350 enrolled
DermatologicGastrointestinalThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma

NCT04374175 2025-03-18

SERPAN

Centre Hospitalier Universitaire de Saint Etienne

Recruiting
400 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

NCT03032913 2018-04-10

PANC-CTC

University Hospital, Bordeaux

Completed
52 enrolled

Adenocarcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡